Co-Authors
This is a "connection" page, showing publications co-authored by Fausto Baldanti and Federica Novazzi.
Connection Strength
1.973
-
SARS-CoV-2 positivity in rectal swabs: implication for possible transmission. J Glob Antimicrob Resist. 2020 09; 22:754-755.
Score: 0.890
-
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy. Nat Commun. 2021 01 19; 12(1):434.
Score: 0.231
-
SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders. Microorganisms. 2020 Jul 15; 8(7).
Score: 0.223
-
Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations. Infect Drug Resist. 2019; 12:1975-1984.
Score: 0.208
-
Molecular Characterization of Influenza Strains in Patients Admitted to Intensive Care Units during the 2017-2018 Season. Int J Mol Sci. 2019 May 30; 20(11).
Score: 0.206
-
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis. 2021 Mar; 104:315-319.
Score: 0.057
-
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay. J Clin Virol. 2020 07; 128:104416.
Score: 0.055
-
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department. J Med Virol. 2020 10; 92(10):1724-1727.
Score: 0.055
-
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis. Dig Liver Dis. 2018 07; 50(7):703-706.
Score: 0.047